The role will support instrument setup and laboratory capability, phase-appropriate formulation and drug product process development, and physicochemical/bioanalytical characterization using state-of-the-art methods and equipment, including but not limited to UPLC or HPLC (SEC, RP, HIC, IEX/CEX, CAD preferred), charge variant analysis, particle analysis, CE-SDS, and other physical-property characterization. Hands-on experience with state-of-the-art bioanalytical methods, including UPLC or HPLC (SEC, RP, HIC, IEX/CEX, CAD preferred), charge variant analysis, particle analysis, CE-SDS, and other physical-property characterization is preferred.